This inventor holds 1 USPTO granted patent. Top assignee: Incyte Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Mi Young Jung: Innovator in Pharmaceutical Combinations
Introduction
Mi Young Jung is a notable inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. Her innovative work has led to the development of a unique patent that showcases her expertise and dedication to advancing medical science.
Latest Patents
Mi Young Jung holds a patent for "Pharmaceutical Combinations for Treating Tumor Comprising Anti-CD19 Antibody and Natural Killer Cell." This patent represents her commitment to finding effective treatments for cancer, utilizing cutting-edge technology and research.
Career Highlights
Currently, Mi Young Jung is employed at Incyte Corporation, a leading biopharmaceutical company. Her role at Incyte allows her to collaborate with other talented professionals in the industry, further enhancing her contributions to pharmaceutical innovations.
Collaborations
Mi Young Jung has worked alongside esteemed colleagues, including Jung Hyun Her and Su Hyun Gwon. These collaborations have fostered a dynamic environment for research and development, leading to groundbreaking advancements in their field.
Conclusion
Mi Young Jung's work exemplifies the spirit of innovation in the pharmaceutical industry. Her dedication to developing effective treatments for tumors highlights the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile